Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advance nerve conduction device CE marked

This article was originally published in Clinica

Executive Summary

NeuroMetrix has CE marked its Advance system for sale in Europe. Advance is used in traditional nerve conduction studies and needle electromyography procedures. It employs a precision electrical stimulator and recording channels for nerve conduction responses and needle electromyography signals. The device also has a high-resolution colour touch screen that permits the review and editing of nerve conduction waveforms. The Waltham, Massachusetts firm intends to begin marketing the product in the UK in the third quarter of 2008, and to expand sales in other countries by the end of the year, through additional European distribution partners. The device gained US FDA 510(k) approval in May (see Clinica No 1305, p 18).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT040858

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel